Elsevier's Maturitas publishes position statement on fertility preservation

November 06, 2013

Amsterdam, November 6, 2013 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of a position statement by the European Menopause and Andropause Society (EMAS) in the journal Maturitas on the topic of fertility preservation.

The rising need for fertility preservation results from two new 21st century changes. Improved survival of malignant disease with gonadotoxic treatments means that long-term reproductive potential should now be considered. Delaying childbirth means that the use of fertility preservation techniques to counter the normal age-related decline in fertility is also becoming a topic of interest for many healthy women.

This EMAS position paper provides and critically appraises evidence on available options for fertility preservation in both pre-pubertal and post-pubertal men and women. EMAS position paper recommends that all men and women of reproductive age should be thoroughly informed before the initiation of any gonadotoxic treatment about the possible risks of the treatment in question and all available options of fertility preservation should be discussed. Fertility preservation should be a priority when treating children or adults of reproductive age with agents that may have hazardous effects on the reproductive system and gonadotoxicity should be kept at a minimum.

These and other recommendations presented in the EMAS' position statement on fertility preservation are published in the article: "EMAS Position statement: Fertility preservation," published in Maturitas, Elsevier; available online on ScienceDirect.
-end-
Notes for editors

Full text of the article is available to credentialed journalists upon request; contact newsroom@elsevier.com Journalists wishing to interview the authors may contact Greyling Peoples, +31 20 485 3323; g.peoples@elsevier.com or editor of Maturitas, Margaret Rees margaret.rees@hotmail.co.uk.

"EMAS Position statement: Fertility preservation" by Gesthimani Mintziori, Irene Lambrinoudaki, Iuliana Ceausu, Herman Depypere, C. Tamer Erel, Faustino R. Pérez-López, Karin Schenck-Gustafsson, Yvonne van der Schouw, Tommaso Simoncini, Florence Tremollieres, Basil C. Tarlatzis, Margaret Rees and Dimitrios G. Goulis. Published in Maturitas (Elsevier), In Press; DOI: 10.1016/j.maturitas.2013.10.010.

About European Menopause and Andropause Society (EMAS)

EMAS promotes the study of midlife health through its journal, congresses, schools and website and encourages the exchange of research and professional experience between members.

Using a range of activities and through its affiliates, EMAS aims to guarantee and provide the same standard of education and information throughout Europe on midlife health in both genders. Recognizing the issues arising from increased longevity the society also provides articles, patient information, web resources, and referrals for healthcare providers in the field and keeps its members up-to-date.http://www.emas-online.org

About Maturitas

Maturitas is an international multidisciplinary peer reviewed scientific journal of midlife health and beyond, publishing original research, reviews, consensus statements and guidelines. The scope encompasses all aspects of postreproductive health in both genders ranging from basic science to health and social care.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact

Greyling Peoples
Elsevier
+31 20 485 3323
g.peoples@elsevier.com

Elsevier

Related Fertility Articles from Brightsurf:

What are your chances of having a second IVF baby after fertility treatment for the first?
As the restrictions on fertility clinics start to be lifted and IVF treatment resumes, research published in Human Reproduction journal offers reassuring news to women who have had to delay their treatment for a second IVF baby because of the coronavirus.

Fertility preservation use among transgender adolescents
Transgender adolescents often seek hormonal intervention to achieve a body consistent with their gender identity and those interventions affect reproductive function.

A new way to assess male fertility
Current tests for male fertility include measuring the concentration and motility of spermatozoa.

Male fertility after chemotherapy: New questions raised
Professor Delb├Ęs, who specializes in reproductive toxicology, conducted a pilot study in collaboration with oncologists and fertility specialists from the McGill University Health Centre (MUHC) on a cohort of 13 patients, all survivors of pediatric leukemia and lymphoma.

Vaping may harm fertility in young women
E-cigarette usage may impair fertility and pregnancy outcomes, according to a mouse study published in the Journal of the Endocrine Society.

Are fertility apps useful?
Researchers at EPFL and Stanford have carried out an analysis of the largest datasets from fertility awareness apps.

Marijuana and fertility: Five things to know
For patients who smoke marijuana and their physicians, 'Five things to know about ... marijuana and fertility' provides useful information for people who may want to conceive.

How could a changing climate affect human fertility?
Human adaptation to climate change may include changes in fertility, according to a new study by an international group of researchers.

Migrants face a trade-off between status and fertility
Researchers from the universities of Helsinki, Turku and Missouri as well as the Family Federation of Finland present the first results from a new, extraordinarily comprehensive population-wide dataset that details the lives of over 160,000 World War II evacuees in terms of integration.

Phthalates may impair fertility in female mice
A phthalate found in many plastic and personal care products may decrease fertility in female mice, a new study found.

Read More: Fertility News and Fertility Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.